Product Information
OPZELURA 1.5% CREAM is a brand product labeled by Incyte Corporation, priced at $34.0201 per GM under NDC 50881000705. Its NADAC has been published 210 times since Jun 22, 2022.
Strength
15 mg/g
Manufacturer
Incyte CorporationNDC
50881000705
Classification
Brand
Dosage Form
CREAM
Route
TOPICAL
Last Updated
6/17/2026
Active Ingredients
RUXOLITINIB PHOSPHATEApproval Type
New Drug (NDA)
FDA Application
NDA215309On Market Since
9/21/2021
Pharmacological Classes
Price Statistics
The NADAC for OPZELURA 1.5% CREAM has been published 210 times since Jun 22, 2022, and over the history we have for it it has risen 8.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $34.0201 per GM |
|---|---|
| All-time high | $34.1433 (May 13, 2026) |
| All-time low | $31.2358 (Jun 22, 2022) |
| 52-week high | $34.1433 |
| 52-week low | $33.4719 |
| Median price | $32.8296 |
| Average price | $32.7616 |
| Largest weekly change | +3.0% (Jan 18, 2023) |
| Weeks tracked | 210 |
| Tracking since | Jun 22, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ruxolitinib market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OPZELURA 1.5% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for OPZELURA 1.5% CREAM, manufactured by Incyte Corporation, is $34.0201 per GM (NDC 50881000705), effective Jun 24, 2026.
How has the price of OPZELURA 1.5% CREAM changed over time?
Over the history we have for it, the NADAC for OPZELURA 1.5% CREAM has risen 8.9%. It has been tracked across 210 weekly CMS publications since Jun 22, 2022.
What are the highest and lowest recorded NADAC prices for OPZELURA 1.5% CREAM?
Since Jun 22, 2022, the NADAC for OPZELURA 1.5% CREAM has ranged from a low of $31.2358 (Jun 22, 2022) to a high of $34.1433 (May 13, 2026), with a median of $32.8296 per GM.
Are there cheaper alternatives to OPZELURA 1.5% CREAM?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OPZELURA 1.5% CREAM, so no direct lower-cost alternative is listed.
Who manufactures OPZELURA 1.5% CREAM?
OPZELURA 1.5% CREAM (NDC 50881000705) is labeled by Incyte Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification